183 related articles for article (PubMed ID: 35859792)
1. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation.
Liu Y; Wang X; Zeng X; Wu Y; Liu X; Tan J; Li X
Open Med (Wars); 2022; 17(1):1183-1202. PubMed ID: 35859792
[TBL] [Abstract][Full Text] [Related]
2. Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation.
Chen Y; Peng W; Tao Q; Li S; Wu Z; Zhou Y; Xu Q; Shu Y; Xu Y; Shao M; Chen M; Shi Y
Lab Invest; 2023 Jan; 103(1):100011. PubMed ID: 36748193
[TBL] [Abstract][Full Text] [Related]
3. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma.
Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
[TBL] [Abstract][Full Text] [Related]
4. miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation.
Fang H; Wu W; Wu Z
Exp Ther Med; 2022 Jul; 24(1):440. PubMed ID: 35720620
[TBL] [Abstract][Full Text] [Related]
5. SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer.
Wu YJ; Huang ST; Chang YH; Lin SY; Lin WL; Chen YJ; Chien ST
Curr Issues Mol Biol; 2023 Sep; 45(10):8013-8026. PubMed ID: 37886949
[TBL] [Abstract][Full Text] [Related]
6. Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
Wang C; Xiao Y; Lao M; Wang J; Xu S; Li R; Xu X; Kuang Y; Shi M; Zou Y; Wang Q; Liang L; Zheng SG; Xu H
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32938830
[TBL] [Abstract][Full Text] [Related]
7. The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer.
Wang Q; Zhong W; Deng L; Lin Q; Lin Y; Liu H; Xu L; Lu L; Chen Y; Huang J; Jiang M; Xiao H; Zhang J; Li H; Lin Y; Song C; Lin Y
Front Cell Dev Biol; 2021; 9():729211. PubMed ID: 34621746
[No Abstract] [Full Text] [Related]
8. Unveiling the Mystery of SUMO-activating enzyme subunit 1: A Groundbreaking Biomarker in the Early Detection and Advancement of Hepatocellular Carcinoma.
Wang H; Yang T; Wu J; Chen D; Wang W
Transplant Proc; 2023 May; 55(4):945-951. PubMed ID: 37236867
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia regulates sumoylation pathways in intervertebral disc cells: implications for hypoxic adaptations.
Wang F; Cai F; Shi R; Wei JN; Wu XT
Osteoarthritis Cartilage; 2016 Jun; 24(6):1113-24. PubMed ID: 26826302
[TBL] [Abstract][Full Text] [Related]
10. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
[TBL] [Abstract][Full Text] [Related]
11. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
Wang Y; Li N; Tian D; Zhou CW; Wang YH; Yang C; Zeng MS
Cancer Manag Res; 2021; 13():6451-6471. PubMed ID: 34429653
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
13. PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS.
Tuccilli C; Baldini E; Sorrenti S; Di Gioia C; Bosco D; Ascoli V; Mian C; Barollo S; Rendina R; Coccaro C; Pepe M; Catania A; Bononi M; Tartaglia F; De Antoni E; D'Armiento M; Ulisse S
J Biol Regul Homeost Agents; 2015; 29(3):655-62. PubMed ID: 26403403
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients.
Sheng H; Hao Z; Zhu L; Zeng Y; He J
BMC Cancer; 2022 May; 22(1):572. PubMed ID: 35606717
[TBL] [Abstract][Full Text] [Related]
15. SUMO-activating SAE1 transcription is positively regulated by Myc.
Amente S; Lavadera ML; Palo GD; Majello B
Am J Cancer Res; 2012; 2(3):330-4. PubMed ID: 22679563
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma.
Zhu P; Ren Q; He N; Zhou C; Jin Q; Gong Z
Oncol Lett; 2021 Mar; 21(3):221. PubMed ID: 33613710
[TBL] [Abstract][Full Text] [Related]
17. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
19. Sortilin-induced lipid accumulation and atherogenesis are suppressed by HNF1b SUMOylation promoted by flavone of
Liu F; Chen S; Ming X; Li H; Zeng Z; Lv Y
J Zhejiang Univ Sci B; 2023 Nov; 24(11):998-1013. PubMed ID: 37961802
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
